Centene and its Texas-based Superior HealthPlan are working
with Community Health Development, Inc. on this project
State-of-the-art community center will provide
access to primary care, behavioral health, youth resources among
other services
ST.
LOUIS, Dec. 5, 2022 /PRNewswire/ -- Centene
Corporation (NYSE: CNC) announced today the Centene Charitable
Foundation and its Texas health
plan, Superior HealthPlan (Superior), have invested $7.9 million in a new, state-of-the-art
multipurpose community center in Uvalde,
Texas. In partnership with Community Health Development,
Inc. (CHDI), a federally qualified health center, the community
center will serve as a whole health resource for the entire
Uvalde community and its
surrounding region. Representatives from Centene, Superior and CHDI
hosted a groundbreaking ceremony on Dec.
2 at the site location.
"Six days after the horrific tragedy at the Robb Elementary
School, Centene and Superior met with CHDI and local leaders to
understand how we could best support Uvalde in what will necessarily be a long-term
recovery," said Sarah London, Chief
Executive Officer of Centene. "As that process continues, expanding
the resources available to the entire community for physical,
mental and emotional health is an important step
forward."
"This project exemplifies what Centene and Superior believe is
critical when it comes to healthcare – that local relationships
enable meaningful and effective healthcare," said Mark Sanders, CEO of Superior HealthPlan.
Once complete, the new community center will house space for
primary medical care, behavioral health services, youth development
resources, college/job preparation training for students, retail
space for local businesses, and a tranquility garden to honor
victims of the tragedy that occurred on May
24, 2022.
"We are honored to partner together and continue serving the
Uvalde community for years to
come," said Mayela Castañon, CEO of CHDI. "Together, with Centene
and Superior, we've expanded access to telehealth services, offered
behavioral health training for providers, and supported the
thousands of Superior members we serve in this area."
The executive committee overseeing the project includes
Mark Sanders of Superior HealthPlan,
Mayela Castañon of CHDI, Lela
Ballesteros of CHDI, Honorable Bill Mitchell of Uvalde, Dr. Hal
Harrell of UCISD, actor Matthew
McConaughey, State Representative Tracy King, Dr. Monica
Gutierrez of Sul Ross University, Tomás León of Equality
Health Foundation and Mary Beth Fisk
of the Uvalde Together Resiliency Center.
The Uvalde Community Center is targeting completion in late
2024.
About Centene Corporation
Centene Corporation, a
Fortune 500 company, is a leading healthcare enterprise that is
committed to helping people live healthier lives. The Company takes
a local approach – with local brands and local teams – to provide
fully integrated, high-quality, and cost-effective services to
government-sponsored and commercial healthcare programs, focusing
on under-insured and uninsured
individuals. Centene offers affordable and high-quality
products to nearly 1 in 15 individuals across the nation, including
Medicaid and Medicare members (including Medicare Prescription Drug
Plans) as well as individuals and families served by
the Health Insurance Marketplace, the TRICARE program, and
individuals in correctional facilities. The Company also contracts
with other healthcare and commercial organizations to provide a
variety of specialty services focused on treating the whole
person. Centene focuses on long-term growth and value
creation as well as the development of its people, systems, and
capabilities so that it can better serve its members, providers,
local communities, and government partners.
Centene uses its investor relations website to publish important
information about the Company, including information that may be
deemed material to investors. Financial and other information about
Centene is routinely posted and is accessible on Centene's investor
relations website, https://investors.centene.com/.
Forward-Looking Statements
All statements, other
than statements of current or historical fact, contained in
this press release are forward-looking
statements. Without limiting the foregoing, forward-looking
statements often use words such as "believe," "anticipate," "plan,"
"expect," "estimate," "intend," "seek," "target," "goal," "may,"
"will," "would," "could," "should," "can," "continue" and other
similar words or expressions (and the negative thereof). Centene
(the Company, our, or we) intends such forward-looking statements
to be covered by the safe-harbor provisions for forward-looking
statements contained in the Private Securities Litigation Reform
Act of 1995, and we are including this statement for purposes of
complying with these safe-harbor provisions. In particular, these
statements include, without limitation, statements about our future
operating or financial performance, market opportunity, value
creation strategy, competition, expected activities in connection
with completed and future acquisitions and dispositions, including
statements about the impact of our recently completed acquisition
of Magellan Health, Inc. (the Magellan Acquisition), other recent
and future acquisitions and dispositions, our investments and the
adequacy of our available cash resources. These forward-looking
statements reflect our current views with respect to future events
and are based on numerous assumptions and assessments made by us in
light of our experience and perception of historical trends,
current conditions, business strategies, operating environments,
future developments and other factors we believe appropriate. By
their nature, forward-looking statements involve known and unknown
risks and uncertainties and are subject to change because they
relate to events and depend on circumstances that will occur in the
future, including economic, regulatory, competitive and other
factors that may cause our or our industry's actual results, levels
of activity, performance or achievements to be materially different
from any future results, levels of activity, performance or
achievements expressed or implied by these forward-looking
statements. These statements are not guarantees of future
performance and are subject to risks, uncertainties and
assumptions. All forward-looking statements included in this press
release are based on information available to us on the date
hereof. Except as may be otherwise required by law, we undertake no
obligation to update or revise the forward-looking statements
included in this press release, whether as a result of new
information, future events or otherwise, after the date
hereof. You should not place undue reliance on any forward-looking
statements, as actual results may differ materially from
projections, estimates, or other forward-looking statements due to
a variety of important factors, variables and events including, but
not limited to: our ability to accurately predict and effectively
manage health benefits and other operating expenses and reserves,
including fluctuations in medical utilization rates due to the
ongoing impact of COVID-19;our ability to maintain or achieve
improvement in the Centers for Medicare and Medicaid Services (CMS)
Star ratings and maintain or achieve improvement in other quality
scores in each case that can impact revenue and future growth; the
risk that the election of new directors, changes in senior
management, and any inability to retain key personnel may create
uncertainty or negatively impact our ability to execute quickly and
effectively; uncertainty as to the expected financial performance
of the combined company following the recent completion of the
Magellan Acquisition; the possibility that the expected
synergies and value creation from the Magellan Acquisition or the
acquisition of WellCare Health Plans, Inc. (the WellCare
Acquisition) or other acquired businesses will not be realized, or
will not be realized within the respective expected time periods;
disruption from the integration of the Magellan Acquisition or the
WellCare Acquisition, unexpected costs, or similar risks from other
acquisitions or dispositions we may announce or complete from time
to time, including potential adverse reactions or changes to
business relationships with customers, employees, suppliers or
regulators, making it more difficult to maintain business and
operational relationships; the risk that the closing conditions,
including applicable regulatory approvals, for the pending
dispositions of Magellan Rx and our Spanish and Central European
businesses, may be delayed or not obtained; impairments to real
estate, investments, goodwill and intangible assets; a downgrade of
the credit rating of our indebtedness; competition; membership and
revenue declines or unexpected trends; changes in healthcare
practices, new technologies, and advances in medicine; increased
healthcare costs; changes in economic, political or market
conditions; changes in federal or state laws or regulations,
including changes with respect to income tax reform or government
healthcare programs as well as changes with respect to the Patient
Protection and Affordable Care Act and the Health Care and
Education Affordability Reconciliation Act (collectively referred
to as the ACA) and any regulations enacted thereunder that may
result from changing political conditions, the current
administration or judicial actions; rate cuts or other payment
reductions or delays by governmental payors and other risks and
uncertainties affecting our government businesses; our ability to
adequately price products; tax matters; disasters or major
epidemics; changes in expected contract start dates; provider,
state, federal, foreign and other contract changes and timing of
regulatory approval of contracts; the expiration, suspension, or
termination of our contracts with federal or state governments
(including, but not limited to, Medicaid, Medicare, TRICARE or
other customers); the difficulty of predicting the timing or
outcome of legal or regulatory proceedings or matters, including,
but not limited to, our ability to resolve claims and/or
allegations made by states with regard to past practices, including
at Envolve Pharmacy Solutions, Inc. (Envolve), as our pharmacy
benefits manager (PBM) subsidiary, within the reserve estimate we
previously recorded and on other acceptable terms, or at all, or
whether additional claims, reviews or investigations relating to
our PBM business will be brought by states, the federal government
or shareholder litigants, or government investigations; the timing
and extent of benefits from our value creation strategy, including
the possibility that the benefits received may be lower than
expected, may not occur, or will not be realized within the
expected time periods; challenges to our contract
awards; cyber-attacks or other privacy or data security incidents;
the exertion of management's time and our resources, and other
expenses incurred and business changes required in connection with
complying with the undertakings in connection with any regulatory,
governmental or third party consents or approvals for acquisitions
or dispositions; any changes in expected closing dates, estimated
purchase price and accretion for acquisitions or dispositions;
restrictions and limitations in connection with our indebtedness;
the availability of debt and equity financing on terms that are
favorable to us; inflation; foreign currency fluctuations; and
risks and uncertainties discussed in the reports that Centene has
filed with the Securities and Exchange Commission. This list of
important factors is not intended to be exhaustive. We discuss
certain of these matters more fully, as well as certain other
factors that may affect our business operations, financial
condition and results of operations, in our filings with the
Securities and Exchange Commission (SEC), including our annual
report on Form 10-K, quarterly reports on Form 10-Q and current
reports on Form 8-K. Due to these important factors and risks, we
cannot give assurances with respect to our future performance,
including without limitation our ability to maintain adequate
premium levels or our ability to control our future medical and
selling, general and administrative costs.
View original content to download
multimedia:https://www.prnewswire.com/news-releases/centene-corporation-invests-7-9-million-in-uvalde-community-center-301694148.html
SOURCE Centene Corporation